Stereotactic Body Radiation Therapy for Spinal Metastases: A Practical Case-based and Patient-Focused Discussion of the New Standard of Care

Recent publications have established SBRT as the standard of care in painful spine metastases. As a result, spine SBRT is being increasingly utilized in both academic and community practices, rendering this educational activity timely. This patient-focused, case-based educational activity reviews the following: 1) Practical applications of data regarding spine SBRT into daily practice including the recently published landmark randomized controlled clinical trial SC24 and TCP/NTCP data from the recently published HyTEC papers, all of which drive the current standard of care. In addition, we anticipate that the manuscript for RTOG 0631 will be published in advance of this activity such that this data will be reviewed and applied. 2) A case-based review of the neurologic, oncologic, mechanical, systemic (NOMS) framework for management of patients with spinal metastases. To highlight the importance of this multi-disciplinary analysis of the optimal management approach, we have a patient speaker sharing their personal experience of how application of this framework directly impacted and improved their quality of life in a durable fashion. 3) We review challenging cases in spine SBRT including safety and planning pearls and interactive Q&A. 

Topics:

  1. Overview of Recently Published Data
    Kristin Redmond, MD, MPH
  2. Case-Based Review of Neurologic, Oncologic, Mechanical, Systemic (NOMS) Framework for Management of Patients with Spinal Metastases 
    Emma M. Dunne, PhD, BS, MBBS 
  3. Challenging Cases in Spine SBRT
    Tim Harris, MD, PhD
  4. Patient Recognition and Q and A
    Full Panel 

This activity is available from December 19, 2023, through 11:59 p.m. Eastern time on December 18, 2025. 

This activity was originally recorded at the 2023 ASTRO Annual Meeting.

Target Audience

The activity is designed to meet the interests of medical oncologists, radiation oncologists, surgeons, physicists, nurses, radiation therapists, radiation dosimetrists and residents. 

Learning Objectives

Upon completion of this activity, participants should be able to do the following:

  • Identify reasonable radiation/dose fractionation schedules and normal tissue constraints for safe and effective spine SBRT.  
  • Determine indications for spine SBRT as well as clinical scenarios in which patients would be better served by alternative interventions such as surgical decompression, stabilization, or conventional RT.  
  • Discuss processes for development and maintenance of an optimal spine SBRT program, including safety pearls and treatment planning considerations.  
Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit™
    The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education for physicians. ASTRO designates this for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • 1.00 Certificate of Attendance
    This activity was designated for 1.00 AMA PRA Category 1 Credit™.
Course opens: 
12/19/2023
Course expires: 
12/18/2025
Cost:
$149.00
Rating: 
0
  • Stephanie K. Schaub, MD, is employed by The University of Washington.  
  • Kristin J. Redmond, MD, MPH, is employed by Johns Hopkins University School of Medicine. Dr. Redmond receives compensation from Elekta AB. Dr. Redmond receives research funding from Accuray, Brainlab, Biomimetix, icotec, Canon, and Gamma tile. She serves on the Advisory board of Camp Kesem.  
  • Emma M. Dunne, PhD, BS, MBBS, is employed by BC Cancer Agency Vancouver.  
  • Tim Harris, MD, PhD, is employed by Virginia Commonwealth University.  

    The person(s) above served as the developer(s) of this activity. Additionally, the Education Committee had control over the content of this activity. All relevant relationships have been mitigated.  
Disclosure link: 
Committee Disclosures

The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing education to physicians.

ASTRO is awarded Deemed Status by the American Board of Radiology to provide SA-CME as part of Part II Maintenance of Certification. 

Available Credit

  • 1.00 AMA PRA Category 1 Credit™
    The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education for physicians. ASTRO designates this for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • 1.00 Certificate of Attendance
    This activity was designated for 1.00 AMA PRA Category 1 Credit™.

Price

Cost:
$149.00
Please login or register to take this course.

Course Fees:
ASTRO members must log in to the ASTRO website to view and receive the member rate.

Nonmember: $149
Member: $99
Member-in-training: $49
Student/Grad Student/PGY: $49
Postdoctoral Fellow: $49
 

Policies:
No refunds, extensions, or substitutions will be made for those participants who, for any reason, have not completed the course by the end of the qualification date. The qualification date for each course is listed in the course catalog on the ASTRO website under availability.

Participants using ASTRO's online courses to satisfy the requirement of a Maintenance of Certification (MOC) program should verify the number, type and availability dates of any course before making a purchase. No refunds, extensions, or substitutions will be made for participants who have purchased courses that do not align with their MOC requirement.

The course and its materials will only be available on the ASTRO website until December 18, 2025, regardless of purchase date. At the expiration of the qualification, participants will no longer have access to the course or its materials. ASTRO reserves the right to remove a course before the end of its qualification period.

Required Hardware/software

One of the two latest versions of Google Chrome, Mozilla Firefox, Internet Explorer or Safari.